Israel Englander Praxis Precision Medicines, Inc. Transaction History

Millennium Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.83 - $1.18 $889,700 - $1.26 Million	1,071,928 Added 609.61%	1,247,765 $1.43 Million
Q1 2023 May 15, 2023	BUY	$0.8 - $4.98 $7,016 - $43,674	8,770 Added 5.25%	175,837 $142,000
Q4 2022 Feb 14, 2023	SELL	$1.88 - $36.45 $1.53 Million - $29.7 Million	-814,871 Reduced 82.99%	167,067 $398,000
Q3 2022 Nov 14, 2022	BUY	$2.5 - $37.95 $1.76 Million - $26.7 Million	704,836 Added 254.36%	981,938 $2.23 Million

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.